| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/26/1999 | CA2321176A1 Connective tissue growth factor homologs |
| 08/26/1999 | CA2321165A1 Antibodies against human cd40 |
| 08/26/1999 | CA2321138A1 Methods for modulating seeds mass by expression of a nucleic acid containing an ap2 domain |
| 08/26/1999 | CA2321106A1 Group b streptococcus antigens |
| 08/26/1999 | CA2321101A1 Modified heat shock protein-antigenic peptide complex |
| 08/26/1999 | CA2321088A1 Method for designing dna-binding proteins of the zinc-finger class |
| 08/26/1999 | CA2320801A1 Insecticidal toxins from photorhabdus |
| 08/26/1999 | CA2320799A1 Secreted proteins and polynucleotides encoding them |
| 08/26/1999 | CA2320632A1 Caf1-related protein |
| 08/26/1999 | CA2319079A1 Pollen specific promoter |
| 08/26/1999 | CA2319039A1 Biotin-binding receptor molecules |
| 08/26/1999 | CA2319038A1 Analgesic peptides from venom of grammostola spatulata and use thereof |
| 08/26/1999 | CA2318811A1 Modulation of cell proliferation, methods and reagents |
| 08/26/1999 | CA2318473A1 Process for concentrating protein with disease-related conformation |
| 08/26/1999 | CA2317922A1 Exo1 and exo2, exocytotic proteins |
| 08/25/1999 | EP0937982A2 Diagnostic and therapeutic agent for treatment of autoimmune hepatitis |
| 08/25/1999 | EP0937777A2 GABA receptors and their uses |
| 08/25/1999 | EP0937735A1 A method for the removal of causative agent(s) of transmissible spongiform encephalopathies from protein solutions |
| 08/25/1999 | EP0937259A1 Process for the extraction of proteins |
| 08/25/1999 | EP0937258A2 Cell stress regulated human mhc class i gene |
| 08/25/1999 | EP0937254A2 METHOD FOR THE INDIRECT DETERMINATION OF THE IN VIVO PRODUCTION OF INTERFERON OF TYPE I BY MEANS OF ANTIBODIES DIRECTED AGAINST Mx HUMAN PROTEINS |
| 08/25/1999 | EP0937155A2 Resistance against nematodes and/or aphids |
| 08/25/1999 | EP0937151A1 Hepatitis c surrogate virus for testing the activity of hepatitis c virus protease, a recombinant gene and a use thereof |
| 08/25/1999 | EP0937150A2 Packaging cell lines for use in facilitating the development of high-capacity adenoviral vectors |
| 08/25/1999 | EP0937149A2 Glucuronide repressors and uses thereof |
| 08/25/1999 | EP0937148A1 Histidine-tagged intimin and methods of using intimin to stimulate an immune response and as an antigen carrier with targeting capability |
| 08/25/1999 | EP0937147A1 Human natural killer cell activating factor ii |
| 08/25/1999 | EP0937145A1 Bmp-4 promoter and use thereof in screening of therapeutic agents for the prevention and/or treatment of osteoporosis |
| 08/25/1999 | EP0937144A1 Human eosinophil-derived basic protein |
| 08/25/1999 | EP0937143A2 Secreted proteins and polynucleotides encoding them |
| 08/25/1999 | EP0937142A2 Secreted proteins and polynucleotides encoding them |
| 08/25/1999 | EP0937141A1 Polynucleotides encoding secreted proteins from human dendritic cells |
| 08/25/1999 | EP0937137A1 Perlecan transgenic animals and methods of identifying compounds for the treatment of amyloidoses |
| 08/25/1999 | EP0937104A1 Endothelium specific expression regulated by epcr control elements |
| 08/25/1999 | EP0937103A2 Compounds and methods for modulating cell adhesion |
| 08/25/1999 | EP0937102A1 Human monocyte chemotactic proprotein |
| 08/25/1999 | EP0937095A1 Targeted cytolysis of cancer cells |
| 08/25/1999 | EP0936922A1 Polynucleotide vaccine formula for treating horse diseases |
| 08/25/1999 | EP0936920A1 NON-IgA Fc BINDING FORMS OF THE GROUP B STREPTOCOCCAL BETA ANTIGENS |
| 08/25/1999 | EP0936919A2 VARIANTS OF HUMAN CILIARY NEUROTROPHIC FACTOR (hCNTF) WITH A RANGE OF ACTION DIFFERENT FROM THAT OF THE WILD-TYPE MOLECULE |
| 08/25/1999 | EP0804566A4 Blue light photoreceptors and methods of using the same |
| 08/25/1999 | EP0804457A4 Modified green fluorescenct proteins |
| 08/25/1999 | EP0682706B1 Novel compounds |
| 08/25/1999 | EP0646016B1 Synthetic peptides for the treatment of myasthenia gravis |
| 08/25/1999 | EP0592566B1 Cysteine depleted il-6 muteins |
| 08/25/1999 | EP0237545B2 Production of pluripotent granulocyte colony-stimulating factor |
| 08/25/1999 | CN1226929A Valtage-gated calcium channel antagonist and methods |
| 08/25/1999 | CN1226925A Phosphate starvation-inducible proteins |
| 08/25/1999 | CN1226899A Synthetic IL-10 analogues |
| 08/25/1999 | CN1226898A Peptides promoting activation of latent TGF-'beta' and method for screening TGF-'beta' activity regulators |
| 08/25/1999 | CN1226897A Isolated peptides derived from mage-2 |
| 08/25/1999 | CN1226896A Modulating activity of hormones or their receptors-peptides, antibodies, vaccines and uses thereof |
| 08/25/1999 | CN1226835A -i gene transfer methods for wound healing |
| 08/24/1999 | US5942664 Isolated mutant bacillus thuringiensis cry1c delta-endotoxin polypeptide having improved insecticidal activity |
| 08/24/1999 | US5942663 Transformed biological protein |
| 08/24/1999 | US5942662 Inducible herbicide resistance |
| 08/24/1999 | US5942658 Genetic engineering |
| 08/24/1999 | US5942620 Methods for producing novel conjugates of thrombin inhibitors |
| 08/24/1999 | US5942607 B7-2: a CTLA4/CD28 ligand |
| 08/24/1999 | US5942606 Coded by polynucleotide |
| 08/24/1999 | US5942599 Oligopeptide analog of carboxy terminus of complement protein; has constrained backbone beta-turn conformation; binds to receptor and is agonist of biological activity; for therapy of immunocompromised/immunodeficient patients |
| 08/24/1999 | US5942496 Methods and compositions for multiple gene transfer into bone cells |
| 08/24/1999 | US5942490 Cell death regulators |
| 08/24/1999 | US5942489 Polypeptides with prolonged antagonistic duration; for treatment of diabetic retinopathy and nephropathy, and acromegaly; anticarcinogenic agents where cancer has somatomedin receptors |
| 08/24/1999 | US5942488 Mutant human beta-globin modified to contain at leaset two non-wild type amino acid residues; enhanced bicarbonate effect |
| 08/24/1999 | US5942487 Composition for treating cornea |
| 08/24/1999 | US5942433 Dna coding for a nucleic acid binding protein with n-terminal modified by addition of acidic amino acids forming domain for stable dimerization or multimerization with cell proteins; for controlling transcription factors by gene therapy |
| 08/24/1999 | US5942429 DEAH-box proteins |
| 08/24/1999 | US5942428 Useful for solving the crystal and solution structures of the tyrosine kinase domains and for identifying compounds that bind to the tyrosine kinase domains and compounds that bind to domains of receptor and non-receptor tyrosine kinase |
| 08/24/1999 | US5942420 Nucleic acid which encodes a follistatin module containing protein; antiproliferative agent and anticarcinogenic agent |
| 08/24/1999 | US5942419 RsbW-1 encoding nucleic acids |
| 08/24/1999 | US5942418 Hydrids; culture product |
| 08/24/1999 | US5942417 CD44-like protein and nucleic acids |
| 08/24/1999 | US5942416 Treatment of infections from bacteria using polypeptides and polynucleotides |
| 08/24/1999 | US5942415 SKAP55 compositions and methods of use therefor |
| 08/24/1999 | US5942414 Polynucleotides encoding human G-protein coupled receptor HIBEF51 |
| 08/24/1999 | US5942413 Polynucleotide fragment that codes an antigen from parasitic worms; antihelmintics |
| 08/24/1999 | US5942412 Polynucleic acid encoding variant insulin-like growth factor I receptor beta subunit and receptor |
| 08/24/1999 | US5942406 Inert support material for avidin-biotin affinity based technology |
| 08/24/1999 | US5942405 Identifying compounds which inhibit complement receptors by mixing cells expressing surface complement receptors with a labeled compound capable of binding receptor and determining if compound inhibits interactions by signal generation |
| 08/24/1999 | US5942404 Diagnosing leukemia by incubating cells with specific antibodies and detecting surface antigens |
| 08/24/1999 | US5942403 Compounds and methods for the detection of t. cruzi infection |
| 08/24/1999 | US5942401 An in vitro assay detecting the presence of cytotoxic t-cell response to rev and or tat proteins |
| 08/24/1999 | US5942400 Assays for detecting β-secretase |
| 08/24/1999 | US5942399 Encoded by polynucleotide |
| 08/24/1999 | US5942398 Nucleic acid molecules encoding glutx and uses thereof |
| 08/24/1999 | US5942389 Developing a genetic suppressor protein with resistance to platinum-based cytotoxic drugs; synthesizing random cdna fragments, transferring dna into expression vector, transducing eukaryotic cells and isolating modified cells |
| 08/24/1999 | US5942274 Recombinant human milk proteins in infant formulas |
| 08/24/1999 | US5942254 An infant milk formulas that have some of the advantageous properties of human milk and avoid the disadvantages with bovine milk such as allergic reactions and incomplete digestion, including a biosynthetic human milk proteins |
| 08/24/1999 | US5942236 Potential vaccine for use against lyme disease to induce a protective immune response in humans by administrating a purified immunogenic outer surface lipoprotein of micelle form |
| 08/24/1999 | US5942235 Exogenous dna encoding an antigenic determinant of a pathogen; recombinant viruses and gene products are useful for cancer therapy |
| 08/24/1999 | US5942234 Hepatitis C virus asialoglycoproteins |
| 08/24/1999 | US5942229 Method for prolonged suppression of humoral immune response to a thymus-dependent antigen therapeutic agent |
| 08/24/1999 | US5942227 Treating type 2 diabetes mellitus or insulin resistance patient |
| 08/24/1999 | US5942223 Antiviral therapy using ovine or bovine interferon-tau |
| 08/24/1999 | US5942222 Administering cytokines macrophage inflammatory proteins (mip-1 and 2) capable of enhancing myelopoietic colony stimulating factor, binding to heparin, and inducing local inflammation having polymorphonuclear cell infiltration |
| 08/24/1999 | US5942221 Recombinant primate granulocyte macrophage-colony stimulating factor |
| 08/24/1999 | US5942220 Inhibitor of cytokine activity and applications thereof |
| 08/24/1999 | CA2248972A1 Novel compounds |
| 08/24/1999 | CA2141475C Type 1 and type p fimbriae-adhesins isolated from novel e. coli strains, process for their preparation and uses thereof |